Our vision is to save your vision
 
Choose Language
  • French
  • Deutsch
  • Italian
  • Russian
  • Japanese
  • Espanol
  • English
Connect and Share
Color: 
    Color Color Color Color
Type size: 
    Size Size Size Size
    Join

Main menu

Skip to primary content
Skip to secondary content
  • Learn
  • Treat
  • Resources
  • Connect
  • About
  • Donate
You need Flash player 8+ and JavaScript enabled to view this video.
If you are seeing distortions, gray spots,
or blurriness in your vision, don't delay.

See your eye doctor.

It may be possible to reverse these
effects.

LEARN about Wet
(neovascular) AMD
Early detection of AMD is crucial to
keeping your vision.

Get the right treatment for Wet AMD:
antiangiogenic therapy.


TREAT Wet AMD
You need Flash player 8+ and JavaScript enabled to view this video.
You need Flash player 8+ and JavaScript enabled to view this video.
News
Archive >


FDA approves faricimab for treatment of wet AMD and DME
Faricimab will be the first and only FDA-approved medicine targeting two distinct pathways, Ang-2 and VEGF-A, involved in retinal diseases and ... Read More >

Novartis Provides Update on Use and Safety of Beovu in Patients With Wet AMD
After the American Society of Retinal Specialists (ASRS) shared a note with its membership warning of vision-threatening cases of occlusive retinal vasculitis of wet AMD drug Beovu, Novartis issued a ... Read More >

Beovu Approved for Wet AMD in European Union
Following the Euopean Medicines Agency (EMA) human medicine’s committee recommendation in December, Beovu (brolucizumab) received formal approval by the European Commission … Source: Read More >

AMD Incidence to Rise by 75% and Affect 77 million Europeans by 2050
In latest calculations, researchers pooled data from 22 prevalence studies involving 55,323 people, aged, on average, between 60 and 81, and from four incidence studies across Europe … Sourc... Read More >

Opthea OPT-302 Combo Outshines Lucentis Alone
At EURETINA 2019 Congress, the Australia based company Ophthea reported data that OPT-302 reduced areas of neovascularization by 38% more and decreased scarring by 39% more, compared to Lucentis alone... Read More >

Positive phase 2 trial results of anti-VEGF abicipar pegol for treating wet AMD
Analysis of data from a Phase 2 study of abicipar pegol (Anti-VEGF DARPin®) in neovascular, or “wet,” age-related macular degeneration (AMD) showed positive results, leading to the decision to ad... Read More >

Call to Action
Learn how early detection by a Retinal Specialist is vital to keeping your vision. Find out what treatments are available for you. Access the right resources. Together, we'll raise awareness.
           
Play Pause
Recent Activity
September 5, 2017
The Angiogenesis Foundation

The Angiogenesis Foundation is launching a useful educational resource on geographic atrophy, the advanced atrophic form of AMD.

The Angiogenesis Foundation will be launching a Geographic Atrophy (GA) Multimedia Educational Toolkit this week at Euretina!

http://www.prnewswire.co.uk/news-releases/the-angiogenesis-foundation-launches-geographic-atrophy-ga-multimedia-educational-toolkit-at-euretina-642658903.html

View on facebook
  • Download Wet AMD Report
  • Glossary
  • Contact Us
  • Privacy Policy
  • Disclaimer
  • Supporters
The Angiogenesis Foundation - One Broadway, 14th fl, Cambridge, MA 02142, (617) 401-2779 amd@angio.org
This website is certified by Health On the Net Foundation. Click to verify.
This site has been determined by HON in Geneva, Switzerland to comply with standards for trustworthy health information.